FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)

CUSIP: 31447P100

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common stock, no par value (the "Shares")
Shares outstanding
34,145,841
Total 13F shares
14,373,653
Share change
-87,444
Total reported value
$89,259,363
Price per share
$6.21
Number of holders
49
Value change
-$593,443
Number of buys
16
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q1 2021

As of 31 Mar 2021, FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,373,653 shares. The largest 10 holders included Southpoint Capital Advisors LP, Sonic Fund II, L.P., Avoro Capital Advisors LLC, BlackRock Inc., 683 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Solas Capital Management, LLC, STATE STREET CORP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and Russell Investments Group, Ltd.. This page lists 49 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.